Showing results (281-290 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|April 16, 2021
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in gliomaJiayi Zhou, Xiaojuan Pei, Yingui Yang, et al.Journal for Immunotherapy of Cancer|October 18, 2014
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre studyUwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, et al.Journal for Immunotherapy of Cancer|October 16, 2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case seriesSowmya Ravi, Kristen Spencer, Mary Ruisi, et al.Journal for Immunotherapy of Cancer|November 10, 2019
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanomaJonathan A Trujillo, Jason J Luke, Yuanyuan Zha, et al.Journal for Immunotherapy of Cancer|December 6, 2019
Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndromeKaram Khaddour, Amy Musiek, Lynn A Cornelius, et al.Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.Journal for Immunotherapy of Cancer|November 22, 2019
Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanismJaina M Patel, Zhihua Cui, Zhi-Fa Wen, et al.Journal for Immunotherapy of Cancer|November 22, 2019
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patientsLenka Kasikova, Michal Hensler, Iva Truxova, et al.Journal for Immunotherapy of Cancer|November 23, 2019
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphomaJia Wei, Xiaojian Zhu, Xia Mao, et al.Journal for Immunotherapy of Cancer|November 23, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samplesEleanor M Scott, Egon J Jacobus, Brian Lyons, et al.Pageof 424